Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Totally appoints administrators as directors step down

(Sharecast News) - Totally is to enter administration and has completed the disposal of its key subsidiaries, the healthcare services company announced on Monday. The move follows a strategic review by Totally in May, which found that selling off divisions was the "only realistic route" to meet its debt obligations over the coming months, after failing to secure approaches for the parent company as a whole.

The firm, which works with hospitals, commissioners and trusts for insourcing and outsourcing services, saw its shares suspended from trade on Friday after filing a notice of intention to appoint administrators.

The board has now appointed Tim Vance and Sam Woodward as joint administrators, with directors Simon Stilwell, John McMullan, Robert Forsyth and Robert Harris all having now resigned.

Following the appointment of administrators, Totally has completed the disposal of its Elective Care and Corporate Wellbeing subsidiaries, as well as the business and assets of the Urgent Care division, to PHL Group.

"Following the appointment of administrators, the company reconfirms that the Strategic Review is not expected to result in any returns to shareholders of Totally," the company said in a statement.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.